BioCryst Pharmaceuticals, Inc. (BCRX)

9.50 -0.02 (-0.21%) USD  |  NASDAQ  |  Apr 17, 16:00
9.50 0.00 (0.00%) Pre-Market: 20:00
More

BioCryst Pharmaceuticals FCF to Assets (TTM)

FCF to Assets (TTM) Chart

View FCF to Assets (TTM) for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View FCF to Assets (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

FCF to Assets (TTM) Range, Past 5 Years

View FCF to Assets (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

FCF to Assets (TTM) Benchmarks

View FCF to Assets (TTM) Benchmarks
Start Trial
Anika Therapeutics, Inc. Upgrade
Lantheus Holdings, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
BioStem Technologies, Inc. Upgrade